Cargando…
Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes
BACKGROUND: The number of older adults with insulin-treated diabetes mellitus (DM) is steadily increasing worldwide. Errors in the insulin injection technique can lead to skin lipohypertrophy (LH), which is the accumulation of fat cells and fibrin in the subcutaneous tissue. While lipohypertrophic l...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843727/ https://www.ncbi.nlm.nih.gov/pubmed/33219928 http://dx.doi.org/10.1007/s13300-020-00954-3 |
_version_ | 1783644204307578880 |
---|---|
author | Gentile, Sandro Guarino, Giuseppina Della Corte, Teresa Marino, Giampiero Fusco, Alessandra Corigliano, Gerardo Colarusso, Sara Piscopo, Marco Improta, Maria Rosaria Corigliano, Marco Martedi, Emilia Oliva, Domenica Russo, Viviana Simonetti, Rosa Satta, Ersilia Romano, Carmine Vaia, Sebastiano Strollo, Felice |
author_facet | Gentile, Sandro Guarino, Giuseppina Della Corte, Teresa Marino, Giampiero Fusco, Alessandra Corigliano, Gerardo Colarusso, Sara Piscopo, Marco Improta, Maria Rosaria Corigliano, Marco Martedi, Emilia Oliva, Domenica Russo, Viviana Simonetti, Rosa Satta, Ersilia Romano, Carmine Vaia, Sebastiano Strollo, Felice |
author_sort | Gentile, Sandro |
collection | PubMed |
description | BACKGROUND: The number of older adults with insulin-treated diabetes mellitus (DM) is steadily increasing worldwide. Errors in the insulin injection technique can lead to skin lipohypertrophy (LH), which is the accumulation of fat cells and fibrin in the subcutaneous tissue. While lipohypertrophic lesions/nodules (LHs) due to incorrect insulin injection techniques are very common, they are often flat and hardly visible and thus require thorough deep palpation examination and ultrasonography (US) for detection. Detection is crucial because such lesions may eventually result in poor diabetes control due to their association with unpredictable insulin release patterns. Skin undergoes fundamental structural changes with aging, possibly increasing the risk for LH. We have therefore investigated the effect of age on the prevalence of LHs and on factors potentially associated with such lesions. METHODS: A total of 1227 insulin-treated outpatients with type 2 DM (T2DM) referred to our diabetes centers were consecutively enrolled in the study. These patients underwent a thorough clinical and US evaluation of the skin at injection sites, as previously described, with up to 95% concordance betweenthe clinical and US screening techniques. Of these 1227 patients, 718 (59%) had LH (LH+) and 509 (41%) were LH-free (LH−). These patients were then assigned to two age class groups (≤ 65 years and > 65 years), and several clinical features, diabetes complication rates, and injection habits were investigated. RESULTS: Comparison of the two age subgroups revealed that 396 (48%) and 322 (79%) patients in the younger and older groups, respectively, had LHs (p < 0.001). Compared to the younger subgroup, the older subgroup displayed a higher LH rate in the abdomen (52.9 vs. 38.3%; p < 0.01) and a lower rate in the arms (25.4 vs. 35.8%; p < 0.05), thighs (26.7 vs. 33.4%; p < 0.05), and buttocks (4.9 vs. 26.2%; p < 0.01). In older subjects, the most relevant parameters were: habit of injecting insulin into LH nodules (56 vs. 47% [younger subjects]; p < 0.01), rate of post-injection leakage of insulin from injection site (drop-leaking rate; 47 vs. 39% [younger subjects]; p < 0.05), and rate of painful injections (5 vs. 16% [younger subjects]; p < 0.001). Multivariate analysis showed a stronger association between LH and poor habits, as well as between several clinical parameters, among which the most relevant were hypoglycemic events and glycemic variability. DISCUSSION: The higher rate of post-injection drop-leaking and pain-free injections might find an explanation in skin changes typically observed in older adults, including lower thickness, vascularity and elasticity, and a more prominent fibrous texture, all of which negatively affect tissue distensibility. Consequently, in addition to the well-known association between aging skin impaired drug absorption rate, aging skin displays a progressively decreasing ability to accommodate large volumes of insulin-containing fluid. CONCLUSIONS: The strong association between LH rate and hypoglycemic events plus glycemic variability suggests the need (1) to take specific actions to prevent and control the high risk of acute cardiovascular events expected to occur in older subjects in the case of hypoglycemic events, and (2) to identify suitable strategies to fulfill the difficult task of performing effective educational programs specifically targeted to the elderly. TRIAL REGISTRATION: Trial registration number 172–11:12.2019, Scientific and Ethical Committee of Campania University “Luigi Vanvitelli”, Naples, Italy). |
format | Online Article Text |
id | pubmed-7843727 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-78437272021-01-29 Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes Gentile, Sandro Guarino, Giuseppina Della Corte, Teresa Marino, Giampiero Fusco, Alessandra Corigliano, Gerardo Colarusso, Sara Piscopo, Marco Improta, Maria Rosaria Corigliano, Marco Martedi, Emilia Oliva, Domenica Russo, Viviana Simonetti, Rosa Satta, Ersilia Romano, Carmine Vaia, Sebastiano Strollo, Felice Diabetes Ther Review BACKGROUND: The number of older adults with insulin-treated diabetes mellitus (DM) is steadily increasing worldwide. Errors in the insulin injection technique can lead to skin lipohypertrophy (LH), which is the accumulation of fat cells and fibrin in the subcutaneous tissue. While lipohypertrophic lesions/nodules (LHs) due to incorrect insulin injection techniques are very common, they are often flat and hardly visible and thus require thorough deep palpation examination and ultrasonography (US) for detection. Detection is crucial because such lesions may eventually result in poor diabetes control due to their association with unpredictable insulin release patterns. Skin undergoes fundamental structural changes with aging, possibly increasing the risk for LH. We have therefore investigated the effect of age on the prevalence of LHs and on factors potentially associated with such lesions. METHODS: A total of 1227 insulin-treated outpatients with type 2 DM (T2DM) referred to our diabetes centers were consecutively enrolled in the study. These patients underwent a thorough clinical and US evaluation of the skin at injection sites, as previously described, with up to 95% concordance betweenthe clinical and US screening techniques. Of these 1227 patients, 718 (59%) had LH (LH+) and 509 (41%) were LH-free (LH−). These patients were then assigned to two age class groups (≤ 65 years and > 65 years), and several clinical features, diabetes complication rates, and injection habits were investigated. RESULTS: Comparison of the two age subgroups revealed that 396 (48%) and 322 (79%) patients in the younger and older groups, respectively, had LHs (p < 0.001). Compared to the younger subgroup, the older subgroup displayed a higher LH rate in the abdomen (52.9 vs. 38.3%; p < 0.01) and a lower rate in the arms (25.4 vs. 35.8%; p < 0.05), thighs (26.7 vs. 33.4%; p < 0.05), and buttocks (4.9 vs. 26.2%; p < 0.01). In older subjects, the most relevant parameters were: habit of injecting insulin into LH nodules (56 vs. 47% [younger subjects]; p < 0.01), rate of post-injection leakage of insulin from injection site (drop-leaking rate; 47 vs. 39% [younger subjects]; p < 0.05), and rate of painful injections (5 vs. 16% [younger subjects]; p < 0.001). Multivariate analysis showed a stronger association between LH and poor habits, as well as between several clinical parameters, among which the most relevant were hypoglycemic events and glycemic variability. DISCUSSION: The higher rate of post-injection drop-leaking and pain-free injections might find an explanation in skin changes typically observed in older adults, including lower thickness, vascularity and elasticity, and a more prominent fibrous texture, all of which negatively affect tissue distensibility. Consequently, in addition to the well-known association between aging skin impaired drug absorption rate, aging skin displays a progressively decreasing ability to accommodate large volumes of insulin-containing fluid. CONCLUSIONS: The strong association between LH rate and hypoglycemic events plus glycemic variability suggests the need (1) to take specific actions to prevent and control the high risk of acute cardiovascular events expected to occur in older subjects in the case of hypoglycemic events, and (2) to identify suitable strategies to fulfill the difficult task of performing effective educational programs specifically targeted to the elderly. TRIAL REGISTRATION: Trial registration number 172–11:12.2019, Scientific and Ethical Committee of Campania University “Luigi Vanvitelli”, Naples, Italy). Springer Healthcare 2020-11-21 2021-01 /pmc/articles/PMC7843727/ /pubmed/33219928 http://dx.doi.org/10.1007/s13300-020-00954-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Review Gentile, Sandro Guarino, Giuseppina Della Corte, Teresa Marino, Giampiero Fusco, Alessandra Corigliano, Gerardo Colarusso, Sara Piscopo, Marco Improta, Maria Rosaria Corigliano, Marco Martedi, Emilia Oliva, Domenica Russo, Viviana Simonetti, Rosa Satta, Ersilia Romano, Carmine Vaia, Sebastiano Strollo, Felice Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes |
title | Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes |
title_full | Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes |
title_fullStr | Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes |
title_full_unstemmed | Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes |
title_short | Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes |
title_sort | lipohypertrophy in elderly insulin-treated patients with type 2 diabetes |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843727/ https://www.ncbi.nlm.nih.gov/pubmed/33219928 http://dx.doi.org/10.1007/s13300-020-00954-3 |
work_keys_str_mv | AT gentilesandro lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT guarinogiuseppina lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT dellacorteteresa lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT marinogiampiero lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT fuscoalessandra lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT coriglianogerardo lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT colarussosara lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT piscopomarco lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT improtamariarosaria lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT coriglianomarco lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT martediemilia lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT olivadomenica lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT russoviviana lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT simonettirosa lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT sattaersilia lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT romanocarmine lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT vaiasebastiano lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT strollofelice lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes AT lipohypertrophyinelderlyinsulintreatedpatientswithtype2diabetes |